{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:39:02Z","timestamp":1761896342938,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista de Psiquiatr\u00eda  y Salud Mental"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.rpsm.2016.05.001","type":"journal-article","created":{"date-parts":[[2016,6,12]],"date-time":"2016-06-12T06:20:58Z","timestamp":1465712458000},"page":"19-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Monitorizaci\u00f3n del riesgo cardiovascular y metab\u00f3lico en ni\u00f1os y adolescentes en tratamiento antipsic\u00f3tico: un estudio descriptivo transversal"],"prefix":"10.1016","volume":"11","author":[{"given":"Miquel","family":"de la Torre Villalobos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Miguel","family":"Martin-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Isabel","family":"Fern\u00e1ndez Sanmart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Pujals Altes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Gasque Llopis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santiago","family":"Batlle Vila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"P\u00e9rez-Sol\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Novo Navarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"G\u00f3mez Sim\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Fresno Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ester","family":"Camprodon Rosanas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Bulbena Vilarrasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpsm.2016.05.001_bib0150","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0924-9338(02)00705-8","article-title":"Use of antipsychotic agents in Spain through 1985-2000","volume":"17","author":"Santamar\u00eda","year":"2002","journal-title":"Eur Psychiatry."},{"key":"10.1016\/j.rpsm.2016.05.001_bib0155","first-page":"25","article-title":"Antipsychotic prescription in children and adolescents: An analysis of data from a German statutory health insurance company from 2005 to 2012","volume":"111","author":"Bachmann","year":"2014","journal-title":"Dtsch Arztebl Int."},{"key":"10.1016\/j.rpsm.2016.05.001_bib0160","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.pedhc.2011.10.009","article-title":"Antipsychotic medication prescribing trends in children and adolescents","volume":"26","author":"Harrison","year":"2012","journal-title":"J Pediatr Health Care."},{"key":"10.1016\/j.rpsm.2016.05.001_bib0165","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00787-014-0563-6","article-title":"Trends in psychopharmacologic treatment of tic disorders in children and adolescents in Germany","volume":"24","author":"Bachmann","year":"2015","journal-title":"Eur Child Adolesc Psychiatry."},{"key":"10.1016\/j.rpsm.2016.05.001_bib0170","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1517\/17425255.2011.562198","article-title":"Antipsychotic drug toxicology in children","volume":"7","author":"Caccia","year":"2011","journal-title":"Expert Opin Drug Metab Toxicol."},{"key":"10.1016\/j.rpsm.2016.05.001_bib0175","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00406-010-0177-z","article-title":"Obesity and coronary risk in patients treated with second-generation antipsychotics","volume":"261","author":"Correll","year":"2011","journal-title":"Eur Arch Psychiatry Clin Neurosci."},{"key":"10.1016\/j.rpsm.2016.05.001_bib0180","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00787-013-0399-5","article-title":"Weight gain and increase of body mass index among children and adolescents treated with antipsychotics: A critical review","volume":"22","author":"Mart\u00ednez-Ortega","year":"2013","journal-title":"Eur Child Adolesc Psychiatry."},{"key":"10.1016\/j.rpsm.2016.05.001_bib0185","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/01.chi.0000220851.94392.30","article-title":"Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents","volume":"45","author":"Correll","year":"2006","journal-title":"J Am Acad Child Adolesc Psychiatry."},{"key":"10.1016\/j.rpsm.2016.05.001_bib0190","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/FTD.0b013e31819f3328","article-title":"Pharmacokinetics and therapeutic drug monitoring of psychotropic drugs in pediatrics","volume":"31","author":"Pichini","year":"2009","journal-title":"Ther Drug Monit."},{"key":"10.1016\/j.rpsm.2016.05.001_bib0195","first-page":"218","article-title":"Evidence-based recommendations for monitoring safety of second generation antipsychotics in children and youth","volume":"20","author":"Pringsheim","year":"2011","journal-title":"J Can Acad Child Adolesc Psychiatry."},{"year":"1994","series-title":"Diagnostic and statistical manual of mental disorders","key":"10.1016\/j.rpsm.2016.05.001_bib0200"},{"key":"10.1016\/j.rpsm.2016.05.001_bib0205","first-page":"137","article-title":"Predictors of metabolic parameter monitoring in adolescents on antipsychotics in a primary care setting","volume":"9","author":"Ghate","year":"2012","journal-title":"Ment Health Fam Med."},{"key":"10.1016\/j.rpsm.2016.05.001_bib0210","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/070674371205700107","article-title":"Waist circumference is a sensitive screening tool for assessment of metabolic syndrome risk in children treated with second-generation antipsychotics","volume":"57","author":"Panagiotopoulos","year":"2012","journal-title":"Can J Psychiatry."},{"key":"10.1016\/j.rpsm.2016.05.001_bib0215","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1742-1241.2010.02564.x","article-title":"Gender-based cardiometabolic risk evaluation in minority and non-minority men grading the evidence of non-traditional determinants of cardiovascular risk","volume":"65","author":"Billups","year":"2011","journal-title":"Int J Clin Pract."},{"key":"10.1016\/j.rpsm.2016.05.001_bib0220","doi-asserted-by":"crossref","first-page":"e1308","DOI":"10.1542\/peds.2014-0828","article-title":"Adherence to guidelines for glucose assessment in starting second-generation antipsychotics","volume":"134","author":"Raebel","year":"2014","journal-title":"Pediatrics."},{"key":"10.1016\/j.rpsm.2016.05.001_bib0225","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1176\/appi.ajp.2008.08030383","article-title":"Prevalence and predictors of lipid and glucose monitoring in commercially insured patients treated with second-generation antipsychotic agents","volume":"166","author":"Haupt","year":"2009","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.rpsm.2016.05.001_bib0230","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.aprim.2012.12.008","article-title":"Effectiveness of a joint project between primary care and mental health to improve the recording of cardiovascular risk factors in patients with psychosis","volume":"45","author":"Vi\u00f1as Cabrera","year":"2013","journal-title":"Aten Primaria."},{"key":"10.1016\/j.rpsm.2016.05.001_bib0235","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s40272-013-0024-6","article-title":"Safety and pharmacokinetics of atypical antipsychotics in children and adolescents","volume":"15","author":"Caccia","year":"2013","journal-title":"Paediatr Drugs."},{"key":"10.1016\/j.rpsm.2016.05.001_bib0240","first-page":"124","article-title":"First do no harm: Promoting an evidence-based approach to atypical antipsychotic use in children and adolescents","volume":"19","author":"Panagiotopoulos","year":"2010","journal-title":"J Can Acad Child Adolesc Psychiatry."},{"key":"10.1016\/j.rpsm.2016.05.001_bib0245","unstructured":"Arango C, Fraguas D, Castro-Fornieles J, Baeza I, Barbeito S, Dolz M, et al. Grupo de trabajo del CIBERSAM para la elaboraci\u00f3n de una gu\u00eda cl\u00ednica y terap\u00e9utica para primeros episodios psic\u00f3ticos en la infancia y adolescencia. Centro de Investigaci\u00f3n Biom\u00e9dica en Red-CIBER; 2014."},{"key":"10.1016\/j.rpsm.2016.05.001_bib0250","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.eurpsy.2010.09.011","article-title":"Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: A systematic review of randomized, placebo controlled trials and guidelines for clinical practice","volume":"26","author":"De Hert","year":"2011","journal-title":"Eur Psychiatry."},{"year":"2008","series-title":"Protocolo de actividades preventivas y de promoci\u00f3n de la salud en la edad pedi\u00e1trica","key":"10.1016\/j.rpsm.2016.05.001_bib0255"},{"key":"10.1016\/j.rpsm.2016.05.001_bib0260","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/JCP.0000000000000190","article-title":"Antipsychotic use in children and adolescents: A 1-year follow-up study","volume":"34","author":"Baeza","year":"2014","journal-title":"J Clin Psychopharmacol."},{"key":"10.1016\/j.rpsm.2016.05.001_bib0265","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.rpsm.2011.07.003","article-title":"Recommendations for switching antipsychotics. A position statement of the Spanish Society of Psychiatry and the Spanish Society of Biological Psychiatry","volume":"4","author":"Bernardo","year":"2011","journal-title":"Rev Psiquiatr Salud Ment (Barc.)."},{"key":"10.1016\/j.rpsm.2016.05.001_bib0270","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.2337\/diacare.27.8.2088-a","article-title":"Consensus development conference on antipsychotic drugs and obesity and diabetes: Response to consensus statement","volume":"27","author":"Boehm","year":"2004","journal-title":"Diabetes Care."},{"key":"10.1016\/j.rpsm.2016.05.001_bib0275","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.4088\/JCP.v66n0818c","article-title":"Consensus development conference on antipsychotic drugs and obesity and diabetes: Response to consensus statement","volume":"66","author":"Citrome","year":"2005","journal-title":"J Clin Psychiatry."},{"key":"10.1016\/j.rpsm.2016.05.001_bib0280","first-page":"75","article-title":"Prescribing second-generation antipsychotic medications: Practice guidelines for general","volume":"54","author":"Horn","year":"2012","journal-title":"BCMJ."},{"key":"10.1016\/j.rpsm.2016.05.001_bib0285","first-page":"134","article-title":"Barriers and facilitators to implementation of a metabolic monitoring protocol in hospital and community settings for second-generation antipsychotic-treated youth","volume":"20","author":"Ronsley","year":"2011","journal-title":"J Can Acad Child Adolesc Psychiatry."},{"key":"10.1016\/j.rpsm.2016.05.001_bib0290","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.rpsm.2010.08.001","article-title":"Caracter\u00edsticas diferenciales de eficacia y tolerabilidad de los antipsic\u00f3ticos de segunda generaci\u00f3n en el tratamiento de trastornos psic\u00f3ticos en ni\u00f1os y adolescentes","volume":"3","author":"Fraguas","year":"2010","journal-title":"Rev Psiquiatr Salud Ment (Barc.)."}],"container-title":["Revista de Psiquiatr\u00eda  y Salud Mental"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1888989116300180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1888989116300180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:32:09Z","timestamp":1761823929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1888989116300180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S1888989116300180"],"URL":"https:\/\/doi.org\/10.1016\/j.rpsm.2016.05.001","relation":{},"ISSN":["1888-9891"],"issn-type":[{"type":"print","value":"1888-9891"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monitorizaci\u00f3n del riesgo cardiovascular y metab\u00f3lico en ni\u00f1os y adolescentes en tratamiento antipsic\u00f3tico: un estudio descriptivo transversal","name":"articletitle","label":"Article Title"},{"value":"Revista de Psiquiatr\u00eda  y Salud Mental","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpsm.2016.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 SEP y SEPB. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}